Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With <i>KRAS</i> Wild-Type Advanced or Metastatic Colorectal Cancer

Alan P. Venook, Donna Niedzwiecki, Heinz-Josef Lenz, Federico Innocenti, Briant Fruth, Jeffrey A. Meyerhardt, Deborah Schrag, Claire Greene, Bert H. O'Neil, James Norman Atkins, Scott Berry, Blase N. Polite, Eileen M. O'Reilly, Richard M. Goldberg, Howard S. Hochster, Richard L. Schilsky, Monica M. Bertagnolli, Anthony B. El-Khoueiry, Peter Watson, Al B. Benson, Daniel L. Mulkerin, Robert J. Mayer, Charles Blanke

Open source

DOI: 10.1001/jama.2017.7105
Published: 2017-06-20
Container: JAMA
Publisher: American Medical Association (AMA)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1001/jama.2017.7105,
  title = {Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With
                    <i>KRAS</i>
                    Wild-Type Advanced or Metastatic Colorectal Cancer},
  author = {Alan P. Venook and Donna Niedzwiecki and Heinz-Josef Lenz and Federico Innocenti and Briant Fruth and Jeffrey A. Meyerhardt and Deborah Schrag and Claire Greene and Bert H. O'Neil and James Norman Atkins and Scott Berry and Blase N. Polite and Eileen M. O'Reilly and Richard M. Goldberg and Howard S. Hochster and Richard L. Schilsky and Monica M. Bertagnolli and Anthony B. El-Khoueiry and Peter Watson and Al B. Benson and Daniel L. Mulkerin and Robert J. Mayer and Charles Blanke},
  year = {2017},
  journal = {JAMA},
  doi = {10.1001/jama.2017.7105},
  url = {https://doi.org/10.1001/jama.2017.7105}
}

RIS

TY  - JOUR
TI  - Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With
                    <i>KRAS</i>
                    Wild-Type Advanced or Metastatic Colorectal Cancer
AU  - Alan P. Venook
AU  - Donna Niedzwiecki
AU  - Heinz-Josef Lenz
AU  - Federico Innocenti
AU  - Briant Fruth
AU  - Jeffrey A. Meyerhardt
AU  - Deborah Schrag
AU  - Claire Greene
AU  - Bert H. O'Neil
AU  - James Norman Atkins
AU  - Scott Berry
AU  - Blase N. Polite
AU  - Eileen M. O'Reilly
AU  - Richard M. Goldberg
AU  - Howard S. Hochster
AU  - Richard L. Schilsky
AU  - Monica M. Bertagnolli
AU  - Anthony B. El-Khoueiry
AU  - Peter Watson
AU  - Al B. Benson
AU  - Daniel L. Mulkerin
AU  - Robert J. Mayer
AU  - Charles Blanke
PY  - 2017
JO  - JAMA
DO  - 10.1001/jama.2017.7105
UR  - https://doi.org/10.1001/jama.2017.7105
ER  -

APA

Venook, A. P., Niedzwiecki, D., Lenz, H., Innocenti, F., Fruth, B., Meyerhardt, J. A., Schrag, D., Greene, C., O'Neil, B. H., Atkins, J. N., Berry, S., Polite, B. N., O'Reilly, E. M., Goldberg, R. M., Hochster, H. S., Schilsky, R. L., Bertagnolli, M. M., El-Khoueiry, A. B., Watson, P., Benson, A. B., Mulkerin, D. L., Mayer, R. J., & Blanke, C. (2017). Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With <i>KRAS</i> Wild-Type Advanced or Metastatic Colorectal Cancer. JAMA. https://doi.org/10.1001/jama.2017.7105

Source records

crossref · retrieved 2026-09-26T20:18:17.326Z